Hemostatic abnormalities at the time of fetal death: A retrospective study evaluating the prevalence and relevance of targeted testing
The risk of confirmed DIC in the context of fetal death is low (1.8%) and primarily associated with retroplacental or vascular pathologies. These findings support a selective approach to hemostasis testing based on clinical context rather than routine systematic testing.
Authors
- Aude Girault (ORCID: https://orcid.org/0000-0002-6101-1200)
- Catherine Fischer (ORCID: https://orcid.org/0000-0001-9352-3027)
- Chloé Lieng
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Maternité Port Royal (FR)
- Centre de Recherche Épidémiologie et Statistique (FR)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1002/ijgo.70713
- Primary Topic
- Blood Coagulation and Thrombosis Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00